Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7152
Delayed Data
As of Apr 27
 -0.0158 / -2.16%
Today’s Change
0.65
Today|||52-Week Range
1.05
+2.17%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.73
Today’s open0.73
Day’s range-- - --
Volume745,770
Average volume (3 months)585,334
Market cap$131.0M
Dividend yield--
Data as of 04/27/2015

Growth & Valuation

Earnings growth (last year)-57.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.90

Competitors

 Today’s
change
Today’s
% change
--United Gene High-Tec...-0.01-6.93%
ARQLArQule Inc-0.10-4.72%
CNATConatus Pharmaceutic...-0.31-4.65%
MRNSMarinus Pharmaceutic...+0.06+0.67%
Data as of 04/27/2015

Financials

Next reporting dateMay 14, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$18.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers